Please login to the form below

Not currently logged in
Email:
Password:

Glyn Edwards appointed interim CEO at the BioIndustry Association

He takes on a leadership role at the UK industry body following the departure of Nigel Gaymond

The UK's BioIndustry Association (BIA) has appointed Glyn Edwards as its interim chief executive.

Edwards was previously CEO at Antisoma from 1998-2011 and prior to this he worked in a variety of business development roles in the biotech and healthcare industries.

Tim Edwards, BIA Chairman, said: “I am delighted that Glyn has been able to join the BIA at this time. Nigel Gaymond has left to pursue other opportunities and I thank him for his engagement with members and his contribution to the BIA over the past two years.

“Glyn's experience as a biotech CEO and a former BIA Board member will be valuable as we continue to develop the BIA.”

Glyn Edwards, BIA interim chief executive, added: “I am looking forward to working with BIA members, its board and staff to help ensure that the UK's life sciences sector is recognised not only here in the UK but also globally.”

24th November 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics